Clinical trials: Pyridoxine Dependant Epilepsy
Pyridoxine Dependant Epilepsy
Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine Dependent Epilepsy Patients
Restricting dietary lysine intake in infants from age 3 months or less with confirmed diagnosis of pyridoxine-dependent epilepsy due to Antiquitin (ATQ) deficiency will: reduce the accumulation of neurotoxic…
- Trial name
- NOEL (NCT01795170)
- Testing
- Lysine Restricted Diet, Pyridoxine
- Where
- 7 sites in United States, Canada and 4 more
- Sponsor
- University of British Columbia
Pyridoxine Dependant Epilepsy
Evaluation of PDE MAX
PDE MAX is a single arm prospective, feasibility study in up to 15 participants aged one (1) year and over of PDE MAX for the dietary management of Pyridoxine Dependent Epilepsy.
- Trial name
- PDE MAX (NCT04672226)
- Testing
- PDE MAX
- Where
- 2 sites in Netherlands, United Kingdom
- Volunteers
- 11 people
- Sponsor
- Vitaflo International, Ltd